Provided by Tiger Fintech (Singapore) Pte. Ltd.

MediWound

16.27
-0.7800-4.57%
Post-market: 16.270.00000.00%16:13 EDT
Volume:239.47K
Turnover:3.92M
Market Cap:175.55M
PE:-5.55
High:16.86
Open:16.86
Low:16.22
Close:17.05
Loading ...

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
19 Mar

Mediwound Ltd expected to post a loss of 61 cents a share - Earnings Preview

Reuters
·
17 Mar

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
03 Mar

MediWound Initiated at Buy by Craig-Hallum

Dow Jones
·
28 Feb

Madrigal (MDGL) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
26 Feb

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

GlobeNewswire
·
25 Feb

MediWound Launches Phase III Trial Evaluating EscharEx for Treating Venous Leg Ulcers

MT Newswires Live
·
12 Feb

MediWound Launches Phase III Trial for EscharEx Targeting Venous Leg Ulcers

TIPRANKS
·
12 Feb

Mediwound Ltd - Interim Analysis Expected in Mid-2026 After 65% Patients Complete Treatment

THOMSON REUTERS
·
12 Feb

Mediwound Ltd - Preparing Phase Ii/Iii Trial for Dfus Expected to Begin in 2026

THOMSON REUTERS
·
12 Feb

Mediwound Initiates the Value Global Phase Iii Pivotal Trial of Escharex® for Treatment of Venous Leg Ulcers

THOMSON REUTERS
·
12 Feb

Mediwound Ltd - to Initiate Phase Ii Study Comparing Escharex to Collagenase in 2025

THOMSON REUTERS
·
12 Feb

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

GlobeNewswire
·
12 Feb

MediWound Ltd.'s (NASDAQ:MDWD) high institutional ownership speaks for itself as stock continues to impress, up 15% over last week

Simply Wall St.
·
28 Jan

MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains?

Zacks
·
27 Jan

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS) and Mediwound (MDWD)

TIPRANKS
·
14 Jan